Glutamine deamidation does not increase the immunogenicity of C-peptide in people with type 1 diabetes

Mannering, 2016, The case for an autoimmune aetiology of type 1 diabetes, Clin. Exp. Immunol., 183, 8, 10.1111/cei.12699 Ziegler, 2016, Type 1 diabetes prevention: a goal dependent on accepting a diagnosis of an asymptomatic disease, Diabetes, 65, 3233, 10.2337/db16-0687 James, 2020, T-cell epitopes and neo-epitopes in type 1 diabetes: a comprehensive update and reappraisal, Diabetes, 69, 1311, 10.2337/dbi19-0022 Noble, 2015, Immunogenetics of type 1 diabetes: a comprehensive review, J. Autoimmun., 64, 101, 10.1016/j.jaut.2015.07.014 Nepom, 1987, Transcomplementation of HLA genes in IDDM. HLA-DQ alpha- and beta-chains produce hybrid molecules in DR3/4 heterozygotes, Diabetes, 36, 114, 10.2337/diab.36.1.114 Krischer, 2019, Predicting islet cell autoimmunity and type 1 diabetes: an 8-year TEDDY study progress report, Diabetes Care, 42, 1051, 10.2337/dc18-2282 Pathiraja, 2015, Proinsulin-specific, HLA-DQ8, and HLA-DQ8-transdimer-restricted CD4+ T cells infiltrate islets in type 1 diabetes, Diabetes, 64, 172, 10.2337/db14-0858 Kent, 2017, Deciphering the pathogenesis of human type 1 diabetes (T1D) by interrogating T cells from the "scene of the crime, Curr. Diabetes Rep., 17, 95, 10.1007/s11892-017-0915-y Michels, 2017, Islet-derived CD4 T cells targeting proinsulin in human autoimmune diabetes, Diabetes, 66, 722, 10.2337/db16-1025 Mannering, 2021, Insulin's other life: an autoantigen in type 1 diabetes, Immunol. Cell Biol., 99, 448, 10.1111/imcb.12442 Wahren, 2015, C-peptide: new findings and therapeutic possibilities, Diabetes Res. Clin. Pract., 107, 309, 10.1016/j.diabres.2015.01.016 So, 2018, Proinsulin C-peptide is an autoantigen in people with type 1 diabetes, Proc. Natl. Acad. Sci. U. S. A, 115, 10732, 10.1073/pnas.1809208115 Musthaffa, 2020, Optimization of a method to detect autoantigen-specific T-cell responses in type 1 diabetes, Front. Immunol., 11, 10.3389/fimmu.2020.587469 Mannering, 2019, Neoepitopes: a new take on beta cell autoimmunity in type 1 diabetes, Diabetologia, 62, 351, 10.1007/s00125-018-4760-6 Rodriguez-Calvo, 2021, diabetes: etiological insights, biomarkers and therapeutic targets, Front. Immunol., 12, 10.3389/fimmu.2021.667989 Mannering, 2005, The insulin A-chain epitope recognized by human T cells is posttranslationally modified, J. Exp. Med., 202, 1191, 10.1084/jem.20051251 Mannering, 2021, Identifying new hybrid insulin peptides (HIPs) in type 1 diabetes, Front. Immunol., 12, 10.3389/fimmu.2021.667870 James, 2018, Immune recognition of beta-cells: neoepitopes as key players in the loss of tolerance, Diabetes, 67, 1035, 10.2337/dbi17-0030 Anderson, 2000, Vivo antigen challenge in celiac disease identifies a single transglutaminase-modified peptide as the dominant A-gliadin T-cell epitope, Nat. Med., 6, 337, 10.1038/73200 Henderson, 2007, A structural and immunological basis for the role of human leukocyte antigen DQ8 in celiac disease, Immunity, 27, 23, 10.1016/j.immuni.2007.05.015 Dunne, 2020, Coeliac disease pathogenesis: the uncertainties of a well-known immune mediated disorder, Front. Immunol., 11, 1374, 10.3389/fimmu.2020.01374 Tye-Din, 2010, Comprehensive, quantitative mapping of T cell epitopes in gluten in celiac disease, Sci. Transl. Med., 2, 41ra51, 10.1126/scitranslmed.3001012 Molberg, 1998, Tissue transglutaminase selectively modifies gliadin peptides that are recognized by gut-derived T cells in celiac disease, Nat. Med., 4, 713, 10.1038/nm0698-713 Marre, 2018, Modifying enzymes are elicited by ER stress, generating epitopes that are selectively recognized by CD4(+) T cells in patients with type 1 diabetes, Diabetes, 67, 1356, 10.2337/db17-1166 Piganelli, 2020, The role of beta cell stress and neo-epitopes in the immunopathology of type 1 diabetes, Front. Endocrinol., 11 van Lummel, 2014, Posttranslational modification of HLA-DQ binding islet autoantigens in type 1 diabetes, Diabetes, 63, 237, 10.2337/db12-1214 McLaughlin, 2016, Human islets and dendritic cells generate post-translationally modified islet autoantigens, Clin. Exp. Immunol., 185, 133, 10.1111/cei.12775 Wan, 2020, The MHC-II peptidome of pancreatic islets identifies key features of autoimmune peptides, Nat. Immunol., 21, 455, 10.1038/s41590-020-0623-7 Insel, 2015, Staging presymptomatic type 1 diabetes: a scientific statement of JDRF, the Endocrine Society, and the American Diabetes Association, Diabetes Care, 38, 1964, 10.2337/dc15-1419 Schneider, 1977, Characterization of EBV-genome negative "null" and "T" cell lines derived from children with acute lymphoblastic leukemia and leukemic transformed non-Hodgkin lymphoma, Int. J. Cancer, 19, 621, 10.1002/ijc.2910190505 Abraham, 2004, Jurkat T cells and development of the T-cell receptor signalling paradigm, Nat. Rev. Immunol., 4, 301, 10.1038/nri1330 Mannering, 2003, A sensitive method for detecting proliferation of rare autoantigen-specific human T cells, J. Immunol. Methods, 283, 173, 10.1016/j.jim.2003.09.004 Mannering, 2004, CD4+ T cell proliferation in response to GAD and proinsulin in healthy, pre-diabetic, and diabetic donors, Ann. N. Y. Acad. Sci., 1037, 16, 10.1196/annals.1337.003 Bartelt, 2009, Comparison of T cell receptor-induced proximal signaling and downstream functions in immortalized and primary T cells, PLoS One, 4, 10.1371/journal.pone.0005430 Delong, 2016, Pathogenic CD4 T cells in type 1 diabetes recognize epitopes formed by peptide fusion, Science, 351, 711, 10.1126/science.aad2791 Tran, 2021, T cell receptor recognition of hybrid insulin peptides bound to HLA-DQ8, Nat. Commun., 12, 5110, 10.1038/s41467-021-25404-x Holland, 2013, Re-directing CD4(+) T cell responses with the flanking residues of MHC class II-bound peptides: the core is not enough, Front. Immunol., 4, 172, 10.3389/fimmu.2013.00172